Del. Vice Chancellor Presses Innoviva On Proxy Deal Drop
By Jeff Montgomery ( July 27, 2017, 9:53 PM EDT) -- A Delaware vice chancellor pressed the CEO of biotech licensing firm Innoviva Inc. Thursday on the company's last-minute walkaway from a director election deal that an activist hedge fund said had settled an April proxy fight....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.